Literature DB >> 3954660

Measurement of blood-retinal barrier function in central retinal vein occlusion.

P S Chahal, T J Fallon, E M Kohner.   

Abstract

Vitreous fluorophotometry was used to measure blood-retinal barrier permeability to fluorescein in eight patients (mean age, 42.9 years; range, 30 to 55 years) with central retinal vein occlusion (CRVO). Permeability coefficient was derived by fitting a mathematical model to the posterior vitreous fluorescence scan and plasma-free fluorescein concentration curve at 60 minutes after intravenous fluorescein sodium (14 mg X kg-1). A permeability index (PI) was estimated by dividing the area under the vitreous fluorescence scan by the area under the plasma-free fluorescein curve. The permeability coefficient and PI were comparable and highly correlated. Initial mean permeability coefficient was 28.78 X 10(-7) cm X s-1 (range, 14.42 X 10(-7) to 41.10 X 10(-7) and 1.89 X 10(-7) cm X s-2 (range, 0.96 X 10(-7) to 2.76 X 10(-7) in eight affected and seven unaffected eyes, respectively. The permeability coefficient and PI in unaffected eyes did not differ significantly from 18 eyes of ten normal subjects. After three to 12 months, permeability coefficient and PI in affected eyes approached the values in the contralateral eyes of four patients with mild and one patient with moderate CRVO but remained elevated in the remaining patients. The permeability coefficient and PI correlated well with changes in severity of retinal appearances on color photographs and fluorescein angiograms. Vitreous fluorophotometry quantitated changes in blood-retinal barrier permeability in CRVO.

Entities:  

Mesh:

Year:  1986        PMID: 3954660     DOI: 10.1001/archopht.1986.01050160110024

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  10 in total

1.  Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits.

Authors:  Lea Scheppke; Edith Aguilar; Ray F Gariano; Ruth Jacobson; John Hood; John Doukas; Jon Cao; Glenn Noronha; Shiyin Yee; Sara Weis; Michael B Martin; Richard Soll; David A Cheresh; Martin Friedlander
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 2.  Ocular fluorophotometry.

Authors:  D J Spalton
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

3.  Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.

Authors:  H J Van Schaik; B Heintz; M Larsen; E Leite; V Rosas; R Schalnus; J A Van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

4.  Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion.

Authors:  Hidetaka Noma; Atsushi Minamoto; Hideharu Funatsu; Hidetoshi Tsukamoto; Kensuke Nakano; Hidetoshi Yamashita; Hiromu K Mishima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-13       Impact factor: 3.117

5.  Vitreous inflammatory factors in macular edema with central retinal vein occlusion.

Authors:  Hidetaka Noma; Hideharu Funatsu; Seiyo Harino; Tatsuya Mimura; Shuichiro Eguchi; Sadao Hori
Journal:  Jpn J Ophthalmol       Date:  2011-05-03       Impact factor: 2.447

6.  Aqueous flare and cells in eyes with retinal vein occlusion--correlation with retinal fluorescein angiographic findings.

Authors:  N X Nguyen; M Küchle
Journal:  Br J Ophthalmol       Date:  1993-05       Impact factor: 4.638

7.  Blood-retina barrier in acute retinal branch vein occlusion.

Authors:  R M Silva; J R Faria de Abreu; J G Cunha-Vaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-11       Impact factor: 3.117

8.  Comparative evaluation between ranibizumab combined with laser and bevacizumab combined with laser versus laser alone for macular oedema secondary to branch retinal vein occlusion.

Authors:  Shorya Vardhan Azad; Amjad Salman; Deepankur Mahajan; Siddharth Sain; Rajvardhan Azad
Journal:  Middle East Afr J Ophthalmol       Date:  2014 Oct-Dec

9.  Changes in the Systemic Expression of Sirtuin-1 and Oxidative Stress after Intravitreal Anti-Vascular Endothelial Growth Factor in Patients with Retinal Vein Occlusion.

Authors:  De-Kuang Hwang; Yuh-Lih Chang; Tai-Chi Lin; Chi-Hsien Peng; Ke-Hung Chien; Ching-Yao Tsai; Shih-Jen Chen; Kuan-Hsuan Chen; Min-Yen Hsu
Journal:  Biomolecules       Date:  2020-10-06

10.  Effect of Extended Release Steroid Implants on the Contralateral Eye.

Authors:  Efrat Fleissig; Douglas Kenneth Sigford
Journal:  BMC Ophthalmol       Date:  2022-03-22       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.